MA56011A - Formulation de comprimé vaginal - Google Patents

Formulation de comprimé vaginal

Info

Publication number
MA56011A
MA56011A MA056011A MA56011A MA56011A MA 56011 A MA56011 A MA 56011A MA 056011 A MA056011 A MA 056011A MA 56011 A MA56011 A MA 56011A MA 56011 A MA56011 A MA 56011A
Authority
MA
Morocco
Prior art keywords
tablet formulation
vaginal tablet
vaginal
formulation
tablet
Prior art date
Application number
MA056011A
Other languages
English (en)
Inventor
Ulf Ellervik
Nils-Olof Lindberg
Sophie Manner
Olov Sterner
Helena Strevens
Annette Säfholm
Original Assignee
Gedea Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gedea Biotech Ab filed Critical Gedea Biotech Ab
Publication of MA56011A publication Critical patent/MA56011A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA056011A 2019-04-05 2020-04-03 Formulation de comprimé vaginal MA56011A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19167495 2019-04-05

Publications (1)

Publication Number Publication Date
MA56011A true MA56011A (fr) 2022-04-06

Family

ID=66101895

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056011A MA56011A (fr) 2019-04-05 2020-04-03 Formulation de comprimé vaginal

Country Status (26)

Country Link
US (2) US12496288B2 (fr)
EP (1) EP3976000B1 (fr)
JP (1) JP7610847B2 (fr)
KR (1) KR102900830B1 (fr)
CN (1) CN113660928B (fr)
AR (1) AR118580A1 (fr)
AU (1) AU2020252268B2 (fr)
BR (1) BR112021019999A2 (fr)
CA (1) CA3134086A1 (fr)
CL (1) CL2021002430A1 (fr)
CO (1) CO2021014253A2 (fr)
EA (1) EA202192716A1 (fr)
ES (1) ES2961736T3 (fr)
HU (1) HUE062772T2 (fr)
IL (1) IL286942B2 (fr)
MA (1) MA56011A (fr)
MX (1) MX2021012146A (fr)
MY (1) MY208388A (fr)
PE (1) PE20220381A1 (fr)
PH (1) PH12021552462A1 (fr)
PL (1) PL3976000T3 (fr)
SG (1) SG11202110236QA (fr)
TW (1) TWI846854B (fr)
UA (1) UA127823C2 (fr)
WO (1) WO2020201515A1 (fr)
ZA (1) ZA202106877B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202090750A1 (ru) 2017-10-06 2020-11-11 Гедеа Биотек Аб Производные глюконовой кислоты для применения в лечении и/или предупреждении инфекций, вызываемых микроорганизмами
WO2024261110A1 (fr) * 2023-06-22 2024-12-26 Gedea Biotech Ab Compositions pour favoriser la croissance de lactobacillus crispatus

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR245888A1 (es) * 1989-01-23 1994-03-30 Merrell Pharma Inc Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
FR2710265B1 (fr) 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
ATE207755T1 (de) * 1998-04-30 2001-11-15 Vesely Renata Maria Cavaliere Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
DE60219965T2 (de) * 2002-04-23 2008-01-17 Lupin Ltd., Mumbai Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
EP1567131A1 (fr) * 2002-11-15 2005-08-31 Ranbaxy Laboratories, Ltd. Formes pharmaceutiques solides a l'hydrochlorure de bupropione
EP1872775A1 (fr) 2006-06-29 2008-01-02 Polichem S.A. Emploi d'une matrice hydrophile contenant un dérivé polyacrylique, un éther de cellulose et un désintégrant, pour la production d'un médicament pour le traitement des troubles génitales d'une femme
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
EA036748B1 (ru) * 2016-04-06 2020-12-16 Гедеа Биотек Аб Глюконо--лактон для лечения вагинальных грибковых инфекций
EA202090750A1 (ru) 2017-10-06 2020-11-11 Гедеа Биотек Аб Производные глюконовой кислоты для применения в лечении и/или предупреждении инфекций, вызываемых микроорганизмами

Also Published As

Publication number Publication date
AU2020252268A1 (en) 2021-10-21
CN113660928A (zh) 2021-11-16
JP2022537478A (ja) 2022-08-26
TW202103693A (zh) 2021-02-01
EP3976000B1 (fr) 2023-08-02
EP3976000C0 (fr) 2023-08-02
PL3976000T3 (pl) 2023-12-04
UA127823C2 (uk) 2024-01-10
MX2021012146A (es) 2021-12-10
PH12021552462A1 (en) 2022-06-13
TWI846854B (zh) 2024-07-01
US12496288B2 (en) 2025-12-16
IL286942A (en) 2021-12-01
WO2020201515A1 (fr) 2020-10-08
JP7610847B2 (ja) 2025-01-09
KR102900830B1 (ko) 2025-12-16
CA3134086A1 (fr) 2020-10-08
MY208388A (en) 2025-05-06
US20260069566A1 (en) 2026-03-12
AR118580A1 (es) 2021-10-20
AU2020252268B2 (en) 2025-05-01
US20220193031A1 (en) 2022-06-23
PE20220381A1 (es) 2022-03-18
ZA202106877B (en) 2023-03-29
CN113660928B (zh) 2024-04-05
HUE062772T2 (hu) 2023-12-28
SG11202110236QA (en) 2021-10-28
IL286942B1 (en) 2024-09-01
KR20210148195A (ko) 2021-12-07
ES2961736T3 (es) 2024-03-13
CO2021014253A2 (es) 2021-11-19
BR112021019999A2 (pt) 2021-12-07
EA202192716A1 (ru) 2022-01-17
IL286942B2 (en) 2025-01-01
EP3976000A1 (fr) 2022-04-06
CL2021002430A1 (es) 2022-07-01

Similar Documents

Publication Publication Date Title
HUE067961T2 (hu) Hüvelyi betét
PL3846674T3 (pl) Wziernik dopochwowy
DK3706615T3 (da) Vaginal speculum
GB201807942D0 (en) Pharmaceutical formulation
EP3761960C0 (fr) Formulation ophtalmique
DK3634377T3 (da) Farmaceutisk formulering
IL278927A (en) pharmaceutical preparation
GB201818183D0 (en) Vaginal speculum
ZA202102871B (en) Pharmaceutical formulation
IL285674A (en) Pharmaceutical formulations
MA44720A (fr) Comprimés à désintégration orale
EP4079252A4 (fr) Système d'appareil médical
EP3630113A4 (fr) Composition pharmaceutique comprenant un inhibiteur de pde9
EP4013441A4 (fr) Formulations de larazotide
EP3881897A4 (fr) Comprimé laxatif
EP3793609C0 (fr) Formulation de solution orale
EP4069523C0 (fr) Dispositif de roulement
MA55882A (fr) Spéculum vaginal
EP3741338C0 (fr) Tampon
EP3976000C0 (fr) Formulation de comprimé vaginal
IL287416A (en) Topical formulation
DK3601277T3 (da) Farmaceutisk formulering
PL3965739T3 (pl) Postacie dawkowane będące tabletkami oleilofosfocholiny
EP3836980C0 (fr) Formulation
PL3823471T3 (pl) Formulacja ulegająca aerozolowaniu